Paul K Wotton - Net Worth and Insider Trading

Paul K Wotton Net Worth

The estimated net worth of Paul K Wotton is at least $5 Million dollars as of 2024-04-28. Paul K Wotton is the President and CEO of Antares Pharma Inc and owns about 708,734 shares of Antares Pharma Inc (ATRS) stock worth over $4 Million. Paul K Wotton is also the Director of Vericel Corp and owns about 26,802 shares of Vericel Corp (VCEL) stock worth over $1 Million. Details can be seen in Paul K Wotton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul K Wotton has not made any transactions after 2023-12-14 and currently still holds the listed stock(s).

Transaction Summary of Paul K Wotton

To

Paul K Wotton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul K Wotton owns 3 companies in total, including Vericel Corp (VCEL) , Ocata Therapeutics Inc (OCAT) , and Antares Pharma Inc (ATRS) .

Click here to see the complete history of Paul K Wotton’s form 4 insider trades.

Insider Ownership Summary of Paul K Wotton

Ticker Comapny Transaction Date Type of Owner
VCEL Vericel Corp 2023-12-14 director
OCAT Ocata Therapeutics Inc 2016-02-10 director & President and CEO
ATRS Antares Pharma Inc 2014-01-15 director

Paul K Wotton Latest Holdings Summary

Paul K Wotton currently owns a total of 2 stocks. Among these stocks, Paul K Wotton owns 708,734 shares of Antares Pharma Inc (ATRS) as of January 15, 2014, with a value of $4 Million and a weighting of 76.25%. Paul K Wotton also owns 26,802 shares of Vericel Corp (VCEL) as of December 14, 2023, with a value of $1 Million and a weighting of 23.75%.

Latest Holdings of Paul K Wotton

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRS Antares Pharma Inc 2014-01-15 708,734 5.59 3,961,823
VCEL Vericel Corp 2023-12-14 26,802 46.05 1,234,232

Holding Weightings of Paul K Wotton


Paul K Wotton Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul K Wotton has made a total of 0 transactions in Antares Pharma Inc (ATRS) over the past 5 years. The most-recent trade in Antares Pharma Inc is the sale of 22,900 shares on January 15, 2014, which brought Paul K Wotton around $116,790.

According to the SEC Form 4 filings, Paul K Wotton has made a total of 2 transactions in Vericel Corp (VCEL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Vericel Corp is the sale of 5,000 shares on December 14, 2023, which brought Paul K Wotton around $186,550.

Insider Trading History of Paul K Wotton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul K Wotton Trading Performance

GuruFocus tracks the stock performance after each of Paul K Wotton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul K Wotton is 35.28%. GuruFocus also compares Paul K Wotton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul K Wotton within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul K Wotton's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul K Wotton

Average Return

148.33%

Average return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.94 35.28 68.32 148.33 82.13 74.24
Relative Return to S&P 500(%) -15.72 27.47 47.59 117.85 61.01 57.4

Paul K Wotton Ownership Network

Ownership Network List of Paul K Wotton

No Data

Ownership Network Relation of Paul K Wotton


Paul K Wotton Owned Company Details

What does Vericel Corp do?

Who are the key executives at Vericel Corp?

Paul K Wotton is the director of Vericel Corp. Other key executives at Vericel Corp include director & President and CEO Dominick Colangelo , Chief Operating Officer Michael Halpin , and SVP & General Counsel Sean C. Flynn .

Vericel Corp (VCEL) Insider Trades Summary

Over the past 18 months, Paul K Wotton made 1 insider transaction in Vericel Corp (VCEL) with a net sale of 5,000. Other recent insider transactions involving Vericel Corp (VCEL) include a net sale of 21,000 shares made by Zerbe Robert L Md , a net sale of 226,787 shares made by Dominick Colangelo , and a net sale of 17,768 shares made by Sean C. Flynn .

In summary, during the past 3 months, insiders sold 137,038 shares of Vericel Corp (VCEL) in total and bought 0 shares, with a net sale of 137,038 shares. During the past 18 months, 303,172 shares of Vericel Corp (VCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 303,172 shares.

Vericel Corp (VCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vericel Corp Insider Transactions

No Available Data

Paul K Wotton Mailing Address

Above is the net worth, insider trading, and ownership report for Paul K Wotton. You might contact Paul K Wotton via mailing address: C/o Antares Pharma, Inc., 707 Eagleview Boulevard, Suite 414, Exton Pa 19341.

Discussions on Paul K Wotton

No discussions yet.